Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Investors Animated Over Aclaris Oral Rheumatoid Arthritis Therapy
MK2 Inhibitor Impresses In Phase IIa
Jan 20 2021
•
By
Kevin Grogan
Aclaris looking to enter lucrative RA field • Source: Archive
More from Immunological
More from Therapeutic Category